StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$26.49−0.91 (-3.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

IDEAYA Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

IDEAYA Biosciences's price to sales ratio was 13.5× on Nov 11, 2026, against 251.3× a year earlier. Over the last 4 years it ranged from 11.7× to 254.2×, with a median of 23.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.5×−235.3
2025Apr 30, 2025248.8×+69.7
2024Oct 31, 2024179.1×+90.3
2023Dec 29, 202388.8×+71.3
2022Dec 30, 202217.5×−8.1
2021Dec 31, 202125.6×–

More IDEAYA Biosciences figures

See a number that looks wrong?